Shares of Nektar Therapeutics (NASDAQ:NKTR) added ~9% in the premarket on Friday after Oppenheimer upgraded the biopharma to ...

In February, in the wake of an international AI Summit in Paris, Anthropic CEO Dario Amodei restated his belief that by 2030 ...

Goldman Sachs analysts are cautioning that “confidence in the US growth story is moderating” and the U.S. stock market may continue to lag behind other global markets.

Imagine a world where AI is embraced as a force for universal progress. Governments, companies, and researchers collaborate ...

Oppenheimer reiterates a Perform rating on Cartesian Therapeutics (RNAC) without a price target following the company’s Q4 report. The ...

Managing Director - Investments CFP The Summa Group of Oppenheimer & Co. Inc. Asset/Investment Management ...

If you missed Oppenheimer in IMAX you can get another chance to see it this weekend with a one-week USA and Canada rerelease ...

Oppenheimer Holdings' profit margin is lacking behind key peers, particularly Morgan Stanley, who is also a key competitor.

In a report released today, Brian Schwartz from Oppenheimer maintained a Hold rating on Sprinklr (CXM – Research Report). The company’s shares ...

Netflix’s CCO Bela Bajaria believes Oppenheimer would have thrived on streaming. But would it really match its box office ...

“Oppenheimer” finally premiered Friday in the nation where two cities were obliterated 79 years ago by the nuclear weapons invented by the American scientist who was the subject of the Oscar ...

Showtime has cast David Dastmalchian ( Oppenheimer) in Dexter: Resurrection in the guest starring role of “Gareth.” ...